pubmed-article:19380447 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0002871 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0937950 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C2349200 | lld:lifeskim |
pubmed-article:19380447 | lifeskim:mentions | umls-concept:C1709595 | lld:lifeskim |
pubmed-article:19380447 | pubmed:issue | 17 | lld:pubmed |
pubmed-article:19380447 | pubmed:dateCreated | 2009-6-9 | lld:pubmed |
pubmed-article:19380447 | pubmed:abstractText | Although numerous clinical trials have demonstrated the efficacy and tolerability of erythropoiesis-stimulating agents (ESAs) in patients with chemotherapy-induced anemia (CIA), results of some recent trials and one meta-analysis have suggested that ESAs may negatively impact survival and/or disease control in patients with cancer. | lld:pubmed |
pubmed-article:19380447 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:language | eng | lld:pubmed |
pubmed-article:19380447 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19380447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19380447 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19380447 | pubmed:month | Jun | lld:pubmed |
pubmed-article:19380447 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:GlaspyJohn... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:OsterborgAnde... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:LudwigHeinzH | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:Vansteenkiste... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:CrawfordJeffr... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:HenryDavid... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:FleishmanAlex... | lld:pubmed |
pubmed-article:19380447 | pubmed:author | pubmed-author:BridgesKenK | lld:pubmed |
pubmed-article:19380447 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19380447 | pubmed:day | 10 | lld:pubmed |
pubmed-article:19380447 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:19380447 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19380447 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19380447 | pubmed:pagination | 2838-47 | lld:pubmed |
pubmed-article:19380447 | pubmed:dateRevised | 2009-11-23 | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:meshHeading | pubmed-meshheading:19380447... | lld:pubmed |
pubmed-article:19380447 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19380447 | pubmed:articleTitle | Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia. | lld:pubmed |
pubmed-article:19380447 | pubmed:affiliation | Wilhelminenspital, Department of Medicine I, Center for Oncology and Hematology, Pavillion 23, Montleartstrasse 37, Vienna 1160, Austria. heinz.ludwig@wienkav.at | lld:pubmed |
pubmed-article:19380447 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19380447 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19380447 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19380447 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19380447 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19380447 | lld:pubmed |